Reading the tape
NASDAQ: NTEC
Intec Pharma Ltd
Healthcare · Biotechnology
Market Cap
$0.00
52w High
$36.80
52w Low
$8.80
P/E
-0.67
Volume
988.30K
Outstanding Shares
0.00
Not enough data to analyse price vs. fundamentals for this ticker.
Company profile
Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel.
CEOJeffrey Meckler
SectorHealthcare
IndustryBiotechnology
Employees36
IPO dateJul 30, 2015
Valuation
Forward P/E—
EV/EBITDA0.01
Enterprise value-$102.6K
Stock splits
Jul 27, 2021↓ Reverse
Every 4 shares became 1
Oct 30, 2020↓ Reverse
Every 20 shares became 1
Profitability & growth
Revenue growth—
Gross margin0%
Operating margin0%
ROE-97.21%▲76.44%vs FY2019
Analyst consensus
RatingBuy
Target price—
2
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2021
Q3 FY21 · EPS est — · Revenue est —
View